Amedeo's Top 20

Amedeo Smart

Independent Medical Education


30 October 2023

Multidisciplinary Journal Club

  1. Piller C.
    Probe of Alzheimer's studies finds 'egregious misconduct'.
    Science 2023;382:251-252.

  1. Messerli FH, Bangalore S, Mandrola JM.
    beta blockers switched to first-line therapy in hypertension.
    Lancet 2023.

  2. Bendszus M, Fiehler J, Subtil F, Bonekamp S, et al.
    Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
    Lancet 2023.

  3. Ahn MJ, Cho BC, Felip E, Korantzis I, et al.
    Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
    N Engl J Med 2023.

  4. Lee YJ, Hong SJ, Kang WC, Hong BK, et al.
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ 2023;383:e075837.

  1. Park S, Kim TM, Han JY, Lee GW, et al.
    A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04).
    J Clin Oncol 2023.

  2. Youssef FF, Liu L, Lin W, Bustamante R, et al.
    Pancreatic Cyst Features Predict for Future Development of Pancreatic Cancer: Results of a Nested Case-Control Study.
    Gastrointest Endosc 2023.

  3. Raychev R, Sun JL, Schwamm L, Smith EE, et al.
    Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines-Stroke Registry.
    Circulation 2023.

  4. Ku E, Copeland T, McCulloch CE, Freise C, et al.
    Peritoneal dialysis catheter complications after insertion by surgeons, radiologists, or nephrologists.
    J Am Soc Nephrol 2023.

  5. Selmaj K, Cree BAC, Barnett M, Thompson A, et al.
    Multiple sclerosis: time for early treatment with high-efficacy drugs.
    J Neurol 2023.

  1. Ishtiak-Ahmed K, Musliner KL, Christensen KS, Mortensen EL, et al.
    Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
    Am J Psychiatry 2023.

  2. Ramos EL, Dayan CM, Chatenoud L, Sumnik Z, et al.
    Teplizumab and beta-Cell Function in Newly Diagnosed Type 1 Diabetes.
    N Engl J Med 2023.

  3. Lu J, Murugesan K, Senchyna F, Budvytiene I, et al.
    Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California.
    J Clin Microbiol 2023.

  4. Shim VC, Baker RJ, Jing W, Puentes R, et al.
    Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system.
    Breast Cancer Res Treat 2023.

  5. Suryavanshi P, Sawant-Pokam P, Clair S, Brennan KC, et al.
    Increased presynaptic excitability in a migraine with aura mutation.
    Brain 2023.

  1. Carbajal-Ochoa W, Bravo-Solarte DC, Bernal AM, Anampa JD, et al.
    Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
    Breast Cancer Res Treat 2023.

  2. Vail EA, Feng R, Sieber F, Carson JL, et al.
    Long-term outcomes with spinal versus general anesthesia for hip fracture surgery: A randomized trial.
    Anesthesiology 2023.

  3. Kuan AS, Chen SP, Wang YF, Wang SJ, et al.
    Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine.
    Cephalalgia 2023;43:333102423120811.

  4. Zinganell A, Gobel G, Berek K, Hofer B, et al.
    Multiple sclerosis in the elderly: a retrospective cohort study.
    J Neurol 2023.

  5. Herlemann A, Cowan JE, Washington SL 3rd, Wong AC, et al.
    Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
    Eur Urol 2023.


more..


Privacy Policy